APA (7 ম সংস্করণ) উদ্ধৃতি

Eaton, C., Wells, J., Holen, I., Croucher, P., & Hamdy, F. (2004). Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতি

Eaton, C., J. Wells, I. Holen, P. Croucher, এবং F. Hamdy. Serum Osteoprotegerin (OPG) Levels Are Associated with Disease Progression and Response to Androgen Ablation in Patients with Prostate Cancer. 2004.

M.L.A (9 ম সংস্করণ) উদ্ধৃতি

Eaton, C., et al. Serum Osteoprotegerin (OPG) Levels Are Associated with Disease Progression and Response to Androgen Ablation in Patients with Prostate Cancer. 2004.